Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis.
Primary congenital glaucoma
aniridia
anterior segment dysgenesis
glaucoma surgery
Journal
European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
pubmed:
11
1
2022
medline:
13
8
2022
entrez:
10
1
2022
Statut:
ppublish
Résumé
To determine the long-term outcomes of a cohort of complex patients with primary congenital glaucoma, aniridia and anterior segment dysgenesis. Retrospective consecutive series between 1990-2021 in two UK tertiary centres: Guy's and St Thomas' NHS Foundation Trust and King's College Hospital NHS Foundation Trust. We recorded the number and types of surgical and laser treatments along with preoperative and postoperative data, including intraocular pressures (IOP) and anti-glaucoma medications. A total of 41 eyes of 21 patients were included. Primary diagnoses were primary congenital glaucoma in 16 eyes (39.0%), aniridia in 14 eyes (34.2%), and anterior segment dysgenesis in 8 eyes (19.5%). Sixteen eyes (39.0%) had one or more glaucoma surgery or laser procedures for advanced glaucoma, and the long-term follow-up was 12.8 ± 3.6 years. There was a significant decrease in postoperative IOP (mmHg) at 3 months (16.5 ± 1.6; Surgical management of these complex eyes with advanced glaucoma is challenging. Overall, the cohort had good surgical outcomes with a significant decrease in IOP by 36.1% after long-term follow-up.
Identifiants
pubmed: 35001688
doi: 10.1177/11206721211073208
pmc: PMC9373187
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2920-2927Subventions
Organisme : Medical Research Council
ID : MR/T027932/1
Pays : United Kingdom
Références
Hum Mol Genet. 2002 May 15;11(10):1185-93
pubmed: 12015278
Arch Ophthalmol. 2010 Apr;128(4):478-82
pubmed: 20385945
Eur J Hum Genet. 2016 Nov;24(11):
pubmed: 27381094
Clin Genet. 2018 Jun;93(6):1123-1130
pubmed: 28972279
Br J Ophthalmol. 1993 Jul;77(7):413-6
pubmed: 8343468
Eur J Paediatr Neurol. 2014 May;18(3):257-66
pubmed: 24275166
Eye (Lond). 2014 Aug;28(8):931-43
pubmed: 24924446
J Appl Genet. 2018 May;59(2):151-159
pubmed: 29460221
Saudi J Ophthalmol. 2019 Oct-Dec;33(4):382-388
pubmed: 31920449
Dev Biol. 2015 Dec 15;408(2):328-44
pubmed: 25724657
Am J Med Genet. 1998 Feb 17;75(5):497-504
pubmed: 9489793
N Engl J Med. 2013 May 23;368(21):1971-9
pubmed: 23656586
Surv Ophthalmol. 2011 Jan-Feb;56(1):68-85
pubmed: 21074819
Clin Exp Ophthalmol. 2004 Feb;32(1):14-8
pubmed: 14746584
Clin Ophthalmol. 2016 May 13;10:871-8
pubmed: 27257371
Clin Genet. 2010 May;77(5):409-20
pubmed: 20132240
Arch Ophthalmol. 1998 Apr;116(4):545-6
pubmed: 9565065
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4100-6
pubmed: 17724193
Eur J Hum Genet. 2018 Nov;26(11):1713-1718
pubmed: 30089822
Am J Ophthalmol. 2006 Mar;141(3):512-6
pubmed: 16490498
Dev Ophthalmol. 1989;16:76-115
pubmed: 2676634
Transl Pediatr. 2014 Jan;3(1):12-24
pubmed: 26835318